[Ip-health] DNDi Welcomes the Political Declaration of the United Nations High-Level Meeting on Antimicrobial Resistance
Rachel M. Cohen
rachel.cohen72 at gmail.com
Wed Sep 21 11:51:15 PDT 2016
DNDi Welcomes the Political Declaration of the United Nations High-Level Meeting on Antimicrobial Resistance
The Drugs for Neglected Diseases initiative (DNDi) welcomes the commitment made by world leaders today at the United Nations (UN) General Assembly to address one of the world’s most pressing public health issues, antimicrobial resistance (AMR).
In May 2016, DNDi and the World Health Organization (WHO) launched the Global Antibiotic R&D Partnership (GARDP) to develop new and affordable antibiotic treatments, including by “delinking” the cost of R&D on AMR from prices and sales.
Today’s UN declaration another encouraging sign that governments have elevated the debate on biomedical innovation and access to medicines, diagnostics and vaccines to the highest political levels.
Response from the Director of the GARD Partnership Dr Manica Balasegaram:
“Today’s political Declaration is a strong first step. More people today are dying from lack of access to health services, appropriate diagnosis, and antibiotics than from drug-resistant infections.
The Declaration is a strong acknowledgement from governments that ‘business as usual’ is not enough to simulate innovation for AMR. Governments must now mobilize new funding for AMR innovation and ensure that there are critical safeguards in place so that there is a public return on public investment.
As called for in today’s Declaration, the WHO can now proceed with developing a Global Development and Stewardship Framework to support the appropriate use of new and existing antibiotics and other health tools. The urgent issue now is translating this political momentum into sustainable financing and concrete actions that can start without delay.”
More information about the Ip-health